Primary Cilium Detection for Immune Disease Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a rapid and effective way to detect indices of immune-related diseases and assist in their diagnosis, particularly by utilizing primary cilia of immune-related cells.
Innovation Solution
A method involving the observation, comparison, and detection of differences in primary cilia of immune-related cells in subject specimens versus normal specimens, using specific binding substances and evaluation kits, to assess immune function and disease presence or severity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection methods are used for immune-related diseases, then the detection process is complex and time-consuming, but the accuracy and objectivity of disease index detection are insufficient
Solution Approach 1:
The patent extracts the primary cilium as a specific biomarker from the complex immune cell structure. By focusing on this particular cellular component that forms during immune cell differentiation, the method simplifies the detection process while maintaining high accuracy for identifying immune-related diseases, thus resolving the contradiction between measurement precision and device complexity
Solution Approach 2:
The patent introduces a specific binding substance as an intermediary to detect primary cilia. This intermediary molecule binds to the primary cilium structure, enabling indirect but accurate detection of immune cell differentiation status, which simplifies the overall detection system while improving measurement precision
2Productivity
If traditional diagnostic approaches are used, then the diagnosis process is subjective and time-consuming, but rapid and objective diagnosis capability is limited
Solution Approach 1:
The patent replaces subjective mechanical examination with an automated molecular detection system. By using specific binding substances to detect primary cilium formation at the molecular level, the system eliminates human subjectivity from the diagnostic process, achieving both rapid and objective diagnosis simultaneously
Solution Approach 2:
The patent changes the detection parameter from general cellular morphology to specific primary cilium formation status. This parameter change enables quantitative, objective measurement of immune cell differentiation, which can be rapidly performed and provides clear diagnostic criteria, resolving the contradiction between diagnosis speed and objectivity
3Productivity
If primary cilium observation method is applied, then rapid and objective detection is achieved, but the method requires specific binding substances and standardized observation protocols
Solution Approach 1:
The patent performs preliminary characterization of primary cilia in normal immune cells during cell differentiation. By establishing baseline knowledge of primary cilium formation patterns before disease detection, the method creates standardized observation criteria that simplify the detection protocol and make it easier to implement while maintaining rapid and objective detection capabilities
Data Source
AI summary
Provided is a method whereby an objective indicator of an immune-related disease can be rapidly and easily detected, the method comprising detecting, as an indicator of an immune-related disease, a difference in the result of observing a primary cilium of an immune-related cell between a subject specimen and a normal specimen.